The CRISPR-Cas system – from bacterial immunity to genome engineering
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Precise and efficient genome modifications present a great value in attempts to comprehend the roles of particular genes and other genetic elements in biological processes as well as in various pathologies. In recent years novel methods of genome modification known as genome editing, which utilize so called “programmable” nucleases, came into use. A true revolution in genome editing has been brought about by the introduction of the CRISP-Cas (clustered regularly interspaced short palindromic repeats-CRISPR associated) system, in which one of such nucleases, i.e. Cas9, plays a major role. This system is based on the elements of the bacterial and archaeal mechanism responsible for acquired immunity against phage infections and transfer of foreign genetic material. Microorganisms incorporate fragments of foreign DNA into CRISPR loci present in their genomes, which enables fast recognition and elimination of future infections. There are several types of CRISPR-Cas systems among prokaryotes but only elements of CRISPR type II are employed in genome engineering. CRISPR-Cas type II utilizes small RNA molecules (crRNA and tracrRNA) to precisely direct the effector nuclease – Cas9 – to a specific site in the genome, i.e. to the sequence complementary to crRNA. Cas9 may be used to: (i) introduce stable changes into genomes e.g. in the process of generation of knock-out and knock-in animals and cell lines, (ii) activate or silence the expression of a gene of interest, and (iii) visualize specific sites in genomes of living cells. The CRISPR-Cas-based tools have been successfully employed for generation of animal and cell models of a number of diseases, e.g. specific types of cancer. In the future, the genome editing by programmable nucleases may find wide application in medicine e.g. in the therapies of certain diseases of genetic origin and in the therapy of HIV-infected patients.
Authors and Affiliations
Maria Czarnek, Joanna Bereta
Keywords
Related Articles
- EP ID EP220848
- DOI -
- Views 147
- Downloads 0
Methotrexate and epirubicin conjugates as potential antitumor drugs
Introduction: The use of hybrid molecules has become one of the most significant approaches in new cytotoxic drug design. This study describes synthesis and characterization of conjugates consisting of two well-known and...
Rola subpopulacji limfocytów pomocniczych Th1, Th17 i Treg w patogenezie reumatoidalnego zapalenia stawów z uwzględnieniem przeciwzapalnego działania cytokin Th1
W patogenezie reumatoidalnego zapalenia stawów (RZS) szczególną rolę przypisuje się zaburzeniom w funkcjonowaniu układu odpornościowego. Przewlekły charakter zapalenia w stawach sugeruje, że regulacja ze strony układu...
Role of PCR in Helicobacter pylori diagnostics and research – new approaches for study of coccoid and spiral forms of the bacteria
Helicobacter pylori since Marshall and Warren’s discovery has been an object of interest of gastroenterologistsand many researchers of other specialties. What needs to be highlighted is also the growing interest of denti...
The presence of some cytokines and Chlamydia pneumoniae in the atherosclerotic carotid plaque in patients with carotid artery stenosis
Background: Over the last few years the role of microorganisms in the pathogenesis of atherosclerosis has been widely discussed. Chlamydia pneumoniae activates immune cells to produce cytokines that are responsible for t...
Identyfikacja profilu ekspresji genów związanego z opornością ex vivo na etopozyd w dziecięcych ostrych białaczkach
Wstęp: Oporność na terapię oraz związany z nią profil ekspresji genów dyskryminują wyniki leczenia, a także wskazują podgrupy pacjentów z niekorzystnym rokowaniem. Celem badań była analiza profilu ekspresji genów w korel...